Companies

Silvergate Capital Corp.

NYSE: SI
$17.87
▼ $0.20 (−1.11%) today
Markets closed · 4:40am ET

SI at a Glance

Valuation
Market cap
$376.2M
P/E ratio
22.3
Profitability
Revenue (TTM)
$60.1M
Price
52-week range
$11 – $49
Street target
$26.50
Earnings
Next report
Nov 10, 2026

Fiscal year ends December NYSE: SI

About Shoulder Innovations

Shoulder Innovations, Inc. (NYSE: SI) is a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market. The company offers advanced implant systems for shoulder arthroplasty, which serve as the core element of its broader ecosystem designed to improve preoperative planning, implant design, and procedural efficiency across all sites of care. The ecosystem also includes enabling technologies, efficient instrument systems, specialized support, and surgeon-to-surgeon collaboration. Shoulder Innovations targets hospitals, ambulatory surgery centers, and orthopedic surgeons, with products addressing both standard and specialty needs such as patients with metal hypersensitivity. The company is also investing in a robotic platform strategic partnership and expanding its product pipeline with new glenosphere and baseplate line extensions for reverse shoulder procedures. Updated

SI Coverage

Frequently Asked Questions

What does Shoulder Innovations do?

Shoulder Innovations, Inc. (NYSE: SI) is a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market.

What is the SI stock price target?

The Wall Street consensus 12-month price target for SI is $26.50.